The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, University of Gothenburg, 41345 Gothenburg, Sweden.
The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, University of Gothenburg, 41345 Gothenburg, Sweden; Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Receptology and Enteroendocrinology, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Trends Endocrinol Metab. 2015 Dec;26(12):758-770. doi: 10.1016/j.tem.2015.09.011. Epub 2015 Nov 7.
The human gut microbiota encompasses a densely populated ecosystem that provides essential functions for host development, immune maturation, and metabolism. Alterations to the gut microbiota have been observed in numerous diseases, including human metabolic diseases such as obesity, type 2 diabetes (T2D), and irritable bowel syndrome, and some animal experiments have suggested causality. However, few studies have validated causality in humans and the underlying mechanisms remain largely to be elucidated. We discuss how systems biology approaches combined with new experimental technologies may disentangle some of the mechanistic details in the complex interactions of diet, microbiota, and host metabolism and may provide testable hypotheses for advancing our current understanding of human-microbiota interaction.
人类肠道微生物群包含一个密集的生态系统,为宿主的发育、免疫成熟和代谢提供了重要功能。在许多疾病中都观察到了肠道微生物群的改变,包括肥胖、2 型糖尿病 (T2D) 和肠易激综合征等人类代谢疾病,一些动物实验也表明了其因果关系。然而,在人类中验证因果关系的研究很少,其潜在机制在很大程度上仍有待阐明。我们讨论了系统生物学方法结合新的实验技术如何在饮食、微生物群和宿主代谢的复杂相互作用中解开一些机制细节,并为我们当前对人类-微生物群相互作用的理解提供可检验的假设。